Merck Staring Down Patent Cliff of Its Lucrative Cancer Wonder Drug
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Merck is looking for a miracle. Well, another one.
The pharma company's patent for its wildly successful "miracle" cancer drug Keytruda is up in 2028 — and a hefty share of its revenues could disappear alongside the exclusivity. On Wednesday, word came that the company is now looking to patch the hole in its future balance sheet by going shopping.
Source Fool.com
